We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals

74 hedge funds and large institutions have $804M invested in Agios Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 21 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 7

91% more capital invested

Capital invested by funds: $420M → $804M (+$384M)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

43% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 21

12% more funds holding

Funds holding: 6674 (+8)

Holders
74
Holders Change
+8
Holders Change %
+12.12%
% of All Funds
2.14%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
16
Increased
30
Reduced
21
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UBS AM
76
UBS AM
Illinois
-$2.61M -108,800 Closed
VAM
77
Visium Asset Management
New York
-$838K -35,000 Closed
TI
78
Turner Investments
Pennsylvania
-$668K -27,880 Closed
Goldman Sachs
79
Goldman Sachs
New York
-$259K -10,812 Closed
SO
80
STRS Ohio
Ohio
-$93.7K -2,800 Closed
California Public Employees Retirement System
81
California Public Employees Retirement System
California
-$24K -1,000 Closed

AGIO Hedge Fund Activity: Q1 2014 in Review

74 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q1 2014, worth a combined $804M — up 91% from $420M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new AGIO positions and 7 closed out — a net gain of 9 holders — while 30 added to existing stakes and 21 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $47.1M. The largest seller was Bain Capital Public Equity Management, cutting an estimated $10.5M.

  • 74 institutional investors held Agios Pharmaceuticals (AGIO) as of Q1 2014, up from 66 in Q4 2013.
  • Funds reported $804M of Agios Pharmaceuticals stock for Q1 2014, up 91% quarter-over-quarter.
  • 16 funds opened new Agios Pharmaceuticals positions in Q1 2014 and 7 closed out, a net change of +9 holders.
  • The largest Agios Pharmaceuticals buyer in Q1 2014 was Fidelity Investments, an estimated $47.1M added.
  • The largest Agios Pharmaceuticals seller in Q1 2014 was Bain Capital Public Equity Management, an estimated $10.5M sold.

Based on aggregated 13F filings for Q1 2014.